Back to results
CompletedPhase 3

Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer

NCT00336791

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

UT MD Anderson Cancer Center

Houston, Texas, United States

+3 additional locations

View on ClinicalTrials.gov